ArticleCurrent ophthalmology reports2017
Polypoidal Choroidal Vasculopathy.
Article in Current ophthalmology reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 15 citations in OpenAlex.
- Management of Traumatic Submacular Hemorrhage by Pneumatic Displacement: A Review.Clinical ophthalmology (Auckland, N.Z.) · 2026Review
- Characterisation of macular neovascularisation subtypes in age-related macular degeneration to optimise treatment outcomes.Eye (London, England) · 2023Review
- Submacular Hemorrhages Show No Significant Seasonal Variations in a European Cohort.Journal of clinical medicine · 2023Article
- Application of Deep Learning for Automated Detection of Polypoidal Choroidal Vasculopathy in Spectral Domain Optical Coherence Tomography.Translational vision science & technology · 2022Article
- Long-term outcomes of focal laser photocoagulation for the treatment of polypoidal choroidal vasculopathy.International journal of ophthalmology · 2021Article
- Profile of retinal diseases in adult patients attending two major eye clinics in Kinshasa, the Democratic Republic of Congo.International journal of ophthalmology · 2020Article
- Polypoidal Choroidal Vasculopathy in Congolese Patients.Journal of ophthalmology · 2020Article
- [Stressed country doctor with acute visual loss : Clear diagnosis?]Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2018Article
- Polypoidal choroidal vasculopathy: An update on current management and review of literature.Taiwan journal of ophthalmologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
purpose of reviewThe goal of this paper is to review the recent literature of polypoidal choroidal vasculopathy (PCV) and provide an update on the epidemiology, pathophysiology, clinical findings, and management. RECENT
findingsAlthough indocyanine-green angiography (ICGA) is still the gold standard for diagnosis of PCV, the use of SUMMARY: PCV is a disease most commonly in Asians and African-Americans and presents with an orange-red nodule in the macula or the peripapillary region. While ICGA remains the most accurate method to diagnose PCV, newer non-invasive imaging modalities (eg. OCT-A and
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.